Developing novel cancer drugs: researchers use patients’ cells to predict response
A collaborative team of researchers have demonstrated that patient-derived cancer cell lines can be used to learn how their tumors will respond to new drugs, increasing the success rate of novel cancer treatment.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.